DOH Steering Committee for the Clinical Trials for COVID-19
The National Steering Committee for the conduct of clinical trials for investigational therapies for COVID-19 is a body that was created by virtue of DPO 2020-1377 to ensure the necessary oversight in the screening and administration of the investigational therapies for COVID-19 patients and ensure their safety and well-being.
Related Issuances
News and updates regarding on the DOH Steering Committee for the Clinical Trials for COVID-19

INFORMATION ON COVID 19 RELATED RESEARCHES AND CLINICAL TRIALS
COVID 19 Related Researches and Clinical Trials Related Posts DOH Steering Committee for the Clinical Trials for COVID-19 07 Oct 2020 cOvid 19 Updates 16 Nov 2020 Philippine Standard time

Process of Patient Referral to COVID 19 Clinical Trials
Department Memorandum 2021-0171 Related Posts cOvid 19 Updates 16 Nov 2020 DOH Steering Committee for the Clinical Trials for COVID-19 07 Oct 2020 Policy Dialogue on Universal Healthcare and Access
PRICE FREEZE FOR TYPHOON ULYSSES
The Department of Health (DOH) imposed a price freeze on emergency essential medicines and medical devices after President Rodrigo Duterte declared a state of calamity

8th DOH Steering Committee Meeting for the Clinical Trials on COVID-19
Undersecrertary Maria Rosario Vergeire of the Health Regulation Team presided the 8th meeting via Zoom. Once again, the latest status of the WHO Solidarity trials for COVID-19 treatments and vaccines

7th DOH Steering Committee Meeting for the Clinical Trials on COVID-19
Today, the DOH Steering Committee for the Conduct of Clinical Trials for investigational treatment for COVID-19 convenes to discuss updates regarding the clinical trials for investigational products (IPs) for COVID-19.
Contact Us:
Telephone Number: 02-8757734 Loc. 253
Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City
Email Address: dohncpam@gmail.com


